Evopoint Biosciences Prices Shanghai IPO to Raise 1.8 Billion Yuan

MT Newswires Live

7 hours ago

Evopoint Biosciences (SHA:688837) priced its initial public offering in Shanghai's STAR Market board of 65.3 million shares, or 15% of its post-IPO share capital, at 27.60 yuan each to raise 1.80 billion yuan, according to a filing with the Shanghai bourse.

The biopharmaceutical company will use the proceeds to fund research and development and working capital.

Online and offline subscriptions will be on Sept. 3.

Guotai Haitong Securities serves as lead underwriter, with China Galaxy Securities as joint lead underwriter.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/news/2664789858"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2664789858\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2664789858?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-02 10:14","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2664789858","market":"nz","top_or_hot":-1,"title":"Evopoint Biosciences Prices Shanghai IPO to Raise 1.8 Billion Yuan","media":"MT Newswires Live","content":"<html><body><p> Evopoint Biosciences (SHA:688837) priced its initial public offering in Shanghai's STAR Market board of 65.3 million shares, or 15% of its post-IPO share capital, at 27.60 yuan each to raise 1.80 billion yuan, according to a filing with the Shanghai bourse.</p><p>The biopharmaceutical company will use the proceeds to fund research and development and working capital.</p><p>Online and offline subscriptions will be on Sept. 3.</p><p><a href=\"https://laohu8.com/S/601211\">Guotai Haitong Securities</a> serves as lead underwriter, with <a href=\"https://laohu8.com/S/CGXYF\">China Galaxy Securities</a> as joint lead underwriter.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Evopoint Biosciences Prices Shanghai IPO to Raise 1.8 Billion Yuan</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEvopoint Biosciences Prices Shanghai IPO to Raise 1.8 Billion Yuan\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-09-02 10:14</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Evopoint Biosciences (SHA:688837) priced its initial public offering in Shanghai's STAR Market board of 65.3 million shares, or 15% of its post-IPO share capital, at 27.60 yuan each to raise 1.80 billion yuan, according to a filing with the Shanghai bourse.</p><p>The biopharmaceutical company will use the proceeds to fund research and development and working capital.</p><p>Online and offline subscriptions will be on Sept. 3.</p><p><a href=\"https://laohu8.com/S/601211\">Guotai Haitong Securities</a> serves as lead underwriter, with <a href=\"https://laohu8.com/S/CGXYF\">China Galaxy Securities</a> as joint lead underwriter.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"REDS","symbol_name":"RPM Republican Senate ETF","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2664789858","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2664789858","pubTimestamp":1788315274,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Evopoint Biosciences  priced its initial public offering in Shanghai's STAR Market board of 65.3 million shares, or 15% of its post-IPO share capital, at 27.60 yuan each to raise 1.80 billion yuan, according to a filing with the Shanghai bourse.The biopharmaceutical company will use the proceeds to fund research and development and working capital.Online and offline subscriptions will be on Sept. 3.Guotai Haitong Securities serves as lead underwriter, with China Galaxy Securities as joint lead underwriter.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"688837":"信诺维-U","REDS":"RPM Republican Senate ETF","KCE":"SPDR KBW Capital Markets ETF","BK4127":"投资银行业与经纪业","FRHC":"Euronext CAC Health Care","IPOS":"Renaissance International IPO ETF"},"translate_title":"Evopoint Biosciences在上海首次公开募股，筹集18亿元人民币","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688837":0.9,"FRHC":1.5,"IPOS":1.5,"REDS":1.5,"KCE":1.5},"content_text":"Evopoint Biosciences (SHA:688837) priced its initial public offering in Shanghai's STAR Market board of 65.3 million shares, or 15% of its post-IPO share capital, at 27.60 yuan each to raise 1.80 billion yuan, according to a filing with the Shanghai bourse.The biopharmaceutical company will use the proceeds to fund research and development and working capital.Online and offline subscriptions will be on Sept. 3.Guotai Haitong Securities serves as lead underwriter, with China Galaxy Securities as joint lead underwriter.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}